Zhuoyi Qiu v. HHS - Influenza, Guillain-Barré Syndrome (“GBS”) and/or Chronic Inflammatory Demyelinating Polyneuropathy (“CIDP”) (2023)

Filed 2021-10-19Decided 2023-06-27Vaccine Influenza
compensated$75,000

Case summary [AI summaries can sometimes make mistakes]

On October 19, 2021, Zhuoyi Qiu filed a petition under the National Vaccine Injury Compensation Program alleging that he suffered from Guillain-Barré Syndrome (GBS) and/or Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) as a result of receiving an influenza vaccine on October 23, 2018. Alternatively, Mr.

Qiu alleged that the flu vaccination significantly aggravated a pre-existing GBS/CIDP condition and that he experienced residual effects for more than six months. The respondent, the Secretary of Health and Human Services, denied that the vaccine caused or aggravated Mr.

Qiu's condition and denied that his current condition was a sequelae of a vaccine-related injury. Despite maintaining their respective positions, both parties agreed to settle the case.

Chief Special Master Brian H. Corcoran reviewed the file and adopted the parties' stipulation.

The stipulation awarded Mr. Qiu a lump sum of $75,000.00, payable by check, as compensation for all damages.

The public decision does not describe the specific onset of symptoms, diagnostic tests, treatments, or expert witnesses. Petitioner was represented by Jeffrey S.

Pop of Jeffrey S. Pop & Associates, and Respondent was represented by Matthew Murphy of the U.S.

Department of Justice.

Theory of causation

Petitioner Zhuoyi Qiu alleged that an October 23, 2018, influenza vaccination caused Guillain-Barré Syndrome (GBS) and/or Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), or alternatively, significantly aggravated a prior GBS/CIDP condition, resulting in residual effects for over six months. Respondent denied causation and aggravation. The parties stipulated to settle the case, with Chief Special Master Brian H. Corcoran adopting the stipulation. The award was $75,000.00. The public decision does not specify the medical mechanism, expert testimony, or detailed evidence supporting the petitioner's theory. The case was filed on October 19, 2021, and the decision was issued on June 27, 2023. Petitioner's counsel was Jeffrey S. Pop, and Respondent's counsel was Matthew Murphy.

Source PDFs 2 total · 1 downloaded